-
Je něco špatně v tomto záznamu ?
Quality of life and drug compliance: their interrelationship in rheumatic patients
L. Hromadkova, T. Soukup, J. Vlcek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26083391
DOI
10.1111/jep.12399
Knihovny.cz E-zdroje
- MeSH
- adherence k farmakoterapii statistika a číselné údaje MeSH
- dospělí MeSH
- juvenilní artritida farmakoterapie psychologie MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- posuzování pracovní neschopnosti MeSH
- průřezové studie MeSH
- revmatické nemoci farmakoterapie psychologie MeSH
- revmatoidní artritida farmakoterapie psychologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- spondylartritida farmakoterapie psychologie MeSH
- stupeň vzdělání MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
RATIONALE, AIMS AND OBJECTIVES: In rheumatic disorders, one of the treatment objectives is to improve the patient's quality of life (QoL). Similar to other chronic conditions, drug compliance is poor, but necessary for successful treatment. The relationship between drug compliance and QoL has never been tested. The aim of this study was to elucidate the relationship between drug compliance and QoL in patients with different rheumatic disorders. METHOD: A cross-sectional study was conducted and patients ≥18 years of age with rheumatoid arthritis (RA), spondyloarthritis (SA), juvenile idiopathic arthritis (JIA) and systemic scleroderma (SSc) were recruited. Data were collected by questionnaires including the Short Form 36 version 2, Compliance Questionnaire Rheumatology (CQR), Health Assessment Questionnaire and by a general questionnaire that focused on demographic characteristics. RESULTS: The questionnaires were completed by 289 patients. Of the respondents, 61.6% (178) were treated for RA, 16.3% (47) for SA, 14.2% (41) for SSc and 8% (23) for JIA. The median of CQR score ranged from 66.7 (JIA) to 82.5 (RA), with 51.6% of patients reaching a score <80. QoL was decreased mainly in the physical component, with the lowest rate for patients with SSc. Higher compliance was observed in patients with decreased QoL (physical component), nevertheless, statistical significance of the relationship was reached only in JIA and SA patients. CONCLUSION: Doctors caring for rheumatic patients should focus their efforts on strengthening drug compliance in patients with higher QoL where it seems that lower compliance is more likely.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020667
- 003
- CZ-PrNML
- 005
- 20160729100811.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jep.12399 $2 doi
- 024 7_
- $a 10.1111/jep.12399 $2 doi
- 035 __
- $a (PubMed)26083391
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hromadkova, Lucie $u Department of Clinical Pharmacy, Hospital Na Homolce, Prague, Czech Republic. Hospital Pharmacy, Masaryk Hospital, Usti nad Labem, Czech Republic.
- 245 10
- $a Quality of life and drug compliance: their interrelationship in rheumatic patients / $c L. Hromadkova, T. Soukup, J. Vlcek,
- 520 9_
- $a RATIONALE, AIMS AND OBJECTIVES: In rheumatic disorders, one of the treatment objectives is to improve the patient's quality of life (QoL). Similar to other chronic conditions, drug compliance is poor, but necessary for successful treatment. The relationship between drug compliance and QoL has never been tested. The aim of this study was to elucidate the relationship between drug compliance and QoL in patients with different rheumatic disorders. METHOD: A cross-sectional study was conducted and patients ≥18 years of age with rheumatoid arthritis (RA), spondyloarthritis (SA), juvenile idiopathic arthritis (JIA) and systemic scleroderma (SSc) were recruited. Data were collected by questionnaires including the Short Form 36 version 2, Compliance Questionnaire Rheumatology (CQR), Health Assessment Questionnaire and by a general questionnaire that focused on demographic characteristics. RESULTS: The questionnaires were completed by 289 patients. Of the respondents, 61.6% (178) were treated for RA, 16.3% (47) for SA, 14.2% (41) for SSc and 8% (23) for JIA. The median of CQR score ranged from 66.7 (JIA) to 82.5 (RA), with 51.6% of patients reaching a score <80. QoL was decreased mainly in the physical component, with the lowest rate for patients with SSc. Higher compliance was observed in patients with decreased QoL (physical component), nevertheless, statistical significance of the relationship was reached only in JIA and SA patients. CONCLUSION: Doctors caring for rheumatic patients should focus their efforts on strengthening drug compliance in patients with higher QoL where it seems that lower compliance is more likely.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a juvenilní artritida $x farmakoterapie $x psychologie $7 D001171
- 650 _2
- $a revmatoidní artritida $x farmakoterapie $x psychologie $7 D001172
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a posuzování pracovní neschopnosti $7 D004185
- 650 _2
- $a stupeň vzdělání $7 D004522
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a adherence k farmakoterapii $x statistika a číselné údaje $7 D055118
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a revmatické nemoci $x farmakoterapie $x psychologie $7 D012216
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a spondylartritida $x farmakoterapie $x psychologie $7 D025241
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Soukup, Tomas $u 2nd Department of Internal Medicine - Gastroenterology, University Hospital and Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
- 700 1_
- $a Vlcek, Jiri $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00006122 $t Journal of evaluation in clinical practice $x 1365-2753 $g Roč. 21, č. 5 (2015), s. 919-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26083391 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160729101034 $b ABA008
- 999 __
- $a ok $b bmc $g 1155337 $s 945195
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 21 $c 5 $d 919-24 $e 20150617 $i 1365-2753 $m Journal of evaluation in clinical practice $n J Eval Clin Pract $x MED00006122
- LZP __
- $a Pubmed-20160722
